Systematic review and meta-analysis of adverse events in clinical trials of mental health apps

Systematic review and meta-analysis of adverse events in clinical trials of mental health apps

Abstract Mental health apps are efficacious, yet they may pose risks in some. This review (CRD42024506486) examined adverse events (AEs) from mental health apps. We searched (May 2024) the Medline, PsycINFO, Web of Science, and ProQuest databases to identify clinical trials of mental health apps. Th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jake Linardon, Matthew Fuller-Tyszkiewicz, Joseph Firth, Simon B. Goldberg, Cleo Anderson, Zoe McClure, John Torous
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-12-01
Series:	npj Digital Medicine
Online Access:	https://doi.org/10.1038/s41746-024-01388-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utility of Consumer-Grade Wearable Devices for Inferring Physical and Mental Health Outcomes in Severe Mental Illness: Systematic Review
by: Lamiece Hassan, et al.
Published: (2025-01-01)

Adverse events associated with endoscopic retrograde cholangiopancreatography: protocol for a systematic review and meta-analysis
by: Marcus Vaska, et al.
Published: (2021-08-01)

Evaluating evaluation frameworks: a scoping review of frameworks for assessing health apps
by: John Torous, et al.
Published: (2021-03-01)

Can social adversity and mental, physical and oral multimorbidity form a syndemic? A concept and protocol paper
by: Easter Joury, et al.
Published: (2025-01-01)

Employabilty and skills handbook for tourism, hospitality and events students /
by: Firth, Miriam
Published: (2020)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Mental Health Monitoring for Young People Through Mood Apps: Protocol for a Scoping Review and Systematic Search in App Stores
by: Selina Boege, et al.
Published: (2024-11-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Assessing Digital Phenotyping for App Recommendations and Sustained Engagement: Cohort Study
by: Bridget Dwyer, et al.
Published: (2024-11-01)

Rituximab-associated adverse events in nephrotic syndrome: A systematic review and meta-analysis
by: Zixian Yu, et al.
Published: (2025-01-01)

A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline
by: Amit Garg, et al.
Published: (2014-07-01)

Working With Similarities and Differences: Relational Processes in Transdisciplinary Qualitative Research With Diverse Teams
by: Michael S. Dao, et al.
Published: (2025-12-01)

A Mobile App–Based Gratitude Intervention’s Effect on Mental Well-Being in University Students: Randomized Controlled Trial
by: Chloë Fuller, et al.
Published: (2025-01-01)

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis
by: Junhui Qian, et al.
Published: (2024-12-01)

ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
by: Navneet Natt, et al.
Published: (2022-01-01)

Rates of Minor Adverse Events and Health Resource Utilization Postcolonoscopy
by: Vladimir Marquez Azalgara, et al.
Published: (2014-01-01)

An infrequent but unpleasant adverse event of Tamsulosin
by: Antonio Villa
Published: (2024-04-01)

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022-01-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024-09-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01)

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
by: Xuhui Tong, et al.
Published: (2025-01-01)

A systematic review and meta-analysis of carfilzomib-associated thrombocytopenia as an adverse event in patients with multiple myeloma
by: Lara Smrdel, et al.
Published: (2024-11-01)

Intervention to improve adverse event reporting in the emergency department: Protocol of a systematic review and meta-analysis.
by: Collins Atta Poku, et al.
Published: (2024-01-01)

Longitudinal trends in the quality, effectiveness and attributes of highly rated smartphone health apps
by: Hannah Wisniewski, et al.
Published: (2020-08-01)

Autoimmune hemolytic anemia, adverse event to venetoclax
by: Carmen Carriles-Fernández, et al.
Published: (2019-09-01)

Rare Adverse Events of CAR T-Cell Therapy
by: Antonia Müller
Published: (2024-03-01)

Contribution of adverse events to death of hospitalised patients
by: Ellinor Christin Haukland, et al.
Published: (2019-01-01)

Faecal microbiota transplantation associated adverse events
by: Patryn Rafal, et al.
Published: (2024-09-01)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
by: Tingting Jiang, et al.
Published: (2025-01-01)

Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System
by: Haiyan Mai, et al.
Published: (2025-01-01)

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
by: Zhengkang Su, et al.
Published: (2024-11-01)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)

Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis
by: Bai-lin Chen, et al.
Published: (2024-12-01)

Understanding the quality, effectiveness and attributes of top-rated smartphone health apps
by: Hannah Wisniewski, et al.

Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
by: Yiming Li, et al.
Published: (2024-12-01)

Mental health apps in India: regulatory landscape and future directions
by: M. I. Singh Sethi, et al.
Published: (2025-02-01)

Responsible Design, Integration, and Use of Generative AI in Mental Health
by: Oren Asman, et al.
Published: (2025-01-01)